©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

Preeya K. Gupta, MD

COVID-19: The Impact on Training Programs
COVID-19: The Impact on Training Programs

Blake K. Williamson, MD, MPH, MS, Gary Wörtz, MD, Preeya Gupta, MD, Royce Chen, MD, Thomas A. Oetting, MD, Uday Devgan, MD

ME LIVE Preview
ME LIVE Preview

Medical Treatment for Presbyopia
Medical Treatment for Presbyopia

Preeya Gupta, MD

Optimizing the Surface
Optimizing the Surface

Chris Starr, MD; Douglas K. Devries, OD; Preeya Gupta, MD; and Leslie E. O’Dell, OD, FAAO

The Expanding Presbyopia Landscape
The Expanding Presbyopia Landscape

Preeya Gupta, MD

Combining Technologies for a Complex Case
Combining Technologies for a Complex Case

Chris Starr, MD; Douglas K. Devries, OD; Preeya Gupta, MD; and Leslie E. O’Dell, OD, FAAO

Maximizing Quality of Life
Maximizing Quality of Life

Chris Starr, MD; Douglas K. Devries, OD; Preeya Gupta, MD; and Leslie E. O’Dell, OD, FAAO

The X-WAVE<sup>TM</sup> Breakthrough
The X-WAVETM Breakthrough

Experts Discuss A Novel Presbyopia Therapeutic Option
Experts Discuss A Novel Presbyopia Therapeutic Option

John Berdahl, MD; Marjan Farid, MD; Preeya Gupta, MD; Edward Holland, MD; John Hovanesian, MD; Mitchell Jackson, MD; Jennifer Loh, MD

Improved Efficiency and Ergonomics With Elara 900
Improved Efficiency and Ergonomics With Elara 900

Preeya K. Gupta, MD

First-Line Treatment for Meibomian Gland Dysfunction
First-Line Treatment for Meibomian Gland Dysfunction

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane<sup>®</sup> iLux2<sup>®</sup>System After 1 Year
Clinical Data From the Systane® iLux2®System After 1 Year

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Advanced Features of the Systane<sup>®</sup> iLux2<sup>®</sup> System
Advanced Features of the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane<sup>®</sup> iLux2<sup>®</sup> System
Clinical Data From the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

What Makes the Systane<sup>®</sup> iLux2<sup>®</sup> Different From Traditional Heat Therapy?
What Makes the Systane® iLux2® Different From Traditional Heat Therapy?

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Biometry Series Webinar 1 – Advanced Keratometry: Taking a Closer Look
Biometry Series Webinar 1 – Advanced Keratometry: Taking a Closer Look

Daniel H. Chang, MD; Preeya K. Gupta, MD; and Douglas Koch, MD

Improve Meibomian Gland Function and Tear Film Stability With Systane<sup>®</sup> iLux2<sup>®</sup>
Improve Meibomian Gland Function and Tear Film Stability With Systane® iLux2®

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

The Near Future in Managing Dry Eye Disease

Preeya K. Gupta, MD; and Christopher E. Starr, MD

Case Studies in Treating Ocular Surface Disease: Season 2

Chris Starr, MD; Preeya Gupta, MD; Douglas DeVries, OD; and Leslie O’Dell, OD

Case Studies in Treating Ocular Surface Disease: Season 2

Survive & Thrive: Private Practice vs Academia

Gary Wörtz, MD; Nandini Venkateswaran, MD; Dagny Zhu, MD; and Preeya Gupta, MD